| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut du Cancer de Montréal, Laboratoires de Recherche, Hôpital Notre-Dame et Université de Montréal, Montréal, Canada
Mice bearing a grafted thyrotropic tumor manifested secondary gonadotropic effects. Ovaries and uterus increased in weight, whereas seminal vesicles were significantly atrophied. These changes were corrected when the growth of the tumor was inhibited with l-thyroxine (T4) or l-triiodothyronine (T3). Attempts to inhibit only the gonadotropic activity with diethylstilbestrol (DES) proved unsuccessful. On the contrary, DES enhanced tumor growth in females with concomitant increase in mean ovarian weight, whereas in males, tumor growth was decreased by DES.
1 This investigation was supported by a grant from the National Cancer Institute of Canada to Dr. A. Cantero, Director of the Research Laboratories, and by funds from the Fondation Biermans.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |